BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10128731)

  • 21. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive therapeutic interchange program in a community hospital.
    Oh T; Franko TG
    Am J Hosp Pharm; 1991 Jul; 48(7):1471-7. PubMed ID: 1882876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P&T Committee overview: Brigham and Women's Hospital.
    Shea BF; Churchill WW; Powell SH; Cooley TW; Maguire JH
    Pharm Pract Manag Q; 1998 Jan; 17(4):76-83. PubMed ID: 10174751
    [No Abstract]   [Full Text] [Related]  

  • 24. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telepharmacology in clinical practice?
    Leskosek B; Ferk P
    Stud Health Technol Inform; 2013; 192():1220. PubMed ID: 23920994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electronic adverse-drug-reaction-reporting program.
    Lee SB; Schepers GP; Goldberg KL
    Am J Health Syst Pharm; 2004 Jun; 61(12):1230, 1232-3. PubMed ID: 15259751
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased adverse drug reaction reporting through wall-mounted ADR reporting cards.
    Szymusiak-Mutnick BA; Ross MB
    Formulary; 1995 Aug; 30(8):471-3. PubMed ID: 10151735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing service delivery and building a data base.
    Disch Plann Update; 1992; 12(6):1, 20-1. PubMed ID: 10123060
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishing a more formal adverse drug reaction reporting system.
    Tse CS; Madura AJ
    Hosp Formul; 1992 Aug; 27(8):845-8. PubMed ID: 10119518
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse drug reaction surveillance and risk management.
    Johnston PE
    Perspect Healthc Risk Manage; 1992; 12(2):22-4. PubMed ID: 10116674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacist clinical intervention program.
    Smith SR; Utterback CM; Parr DD; Waller DJ
    Top Hosp Pharm Manage; 1993 Jul; 13(2):1-15. PubMed ID: 10128810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-usage evaluation in the community hospital.
    Schatz LN; Hahn RF
    Top Hosp Pharm Manage; 1991 Apr; 11(1):80-6. PubMed ID: 10128609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closing the loop of patient care--a clinical trial of a computerized discharge medication program.
    Sands DZ; Safran C
    Proc Annu Symp Comput Appl Med Care; 1994; ():841-5. PubMed ID: 7950043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventability and severity assessment in reporting adverse drug reactions.
    Hartwig SC; Siegel J; Schneider PJ
    Am J Hosp Pharm; 1992 Sep; 49(9):2229-32. PubMed ID: 1524068
    [No Abstract]   [Full Text] [Related]  

  • 40. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.